Publication:
Flavaglines as natural products targeting eIF4A and prohibitins: From traditional Chinese medicine to antiviral activity against coronaviruses

dc.contributor.authorCanan G. Nebigilen_US
dc.contributor.authorChristiane Moogen_US
dc.contributor.authorStéphan Vagneren_US
dc.contributor.authorNadia Benkirane-Jesselen_US
dc.contributor.authorDuncan R. Smithen_US
dc.contributor.authorLaurent Désaubryen_US
dc.contributor.otherUniversite Paris-Saclayen_US
dc.contributor.otherUniversité de Strasbourgen_US
dc.contributor.otherInstitut Curieen_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherLes Hôpitaux Universitaires de Strasbourgen_US
dc.contributor.otherInsermen_US
dc.date.accessioned2020-08-25T09:27:17Z
dc.date.available2020-08-25T09:27:17Z
dc.date.issued2020-10-01en_US
dc.description.abstract© 2020 Elsevier Masson SAS Flavaglines are cyclopenta[b]benzofurans found in plants of the genus Aglaia, several species of which are used in traditional Chinese medicine. These compounds target the initiation factor of translation eIF4A and the scaffold proteins prohibitins-1 and 2 (PHB1/2) to exert various pharmacological activities, including antiviral effects against several types of viruses, including coronaviruses. This review is focused on the antiviral effects of flavaglines and their therapeutic potential against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).en_US
dc.identifier.citationEuropean Journal of Medicinal Chemistry. Vol.203, (2020)en_US
dc.identifier.doi10.1016/j.ejmech.2020.112653en_US
dc.identifier.issn17683254en_US
dc.identifier.issn02235234en_US
dc.identifier.other2-s2.0-85088007294en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/123456789/57806
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088007294&origin=inwarden_US
dc.subjectChemistryen_US
dc.subjectPharmacology, Toxicology and Pharmaceuticsen_US
dc.titleFlavaglines as natural products targeting eIF4A and prohibitins: From traditional Chinese medicine to antiviral activity against coronavirusesen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85088007294&origin=inwarden_US

Files

Collections